JATT Acquisition, a blank check company targeting life sciences technology, raised $120 million by offering 12 million units at $10. Each unit consists of one share of common stock and one-half of a ...
Zura Bio Limited to trade on Nasdaq as a clinical-stage biotechnology company focused on immunology Business combination results in approximately $65 million in gross cash proceeds to support research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback